AptarGroup has acquired drug delivery training devices and patient onboarding company Noble International. This acquisition furthers Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers through all stages of their drug development journey.
The proper administration of certain medications can be challenging, especially when patients are required to administer the medication themselves. With the movement of treatments from the healthcare provider to the home, the need to ensure accurate, consistent and safe use of the device becomes a critical component of the effectiveness of the treatment.
This strategic acquisition meets Aptar’s approach of acquiring companies with strong positions in attractive markets, proprietary technologies and robust growth fundamentals. The combination of Noble and Aptar will bring additional value to pharmaceutical customers as they seek to put more life-changing treatments into the hands of empowered patients.